<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04719871</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0696</org_study_id>
    <nct_id>NCT04719871</nct_id>
  </id_info>
  <brief_title>Vitreous Detachment and Glaucoma Progression</brief_title>
  <acronym>REVEAL</acronym>
  <official_title>Rate of Visual Field Progression Before and After Posterior Vitreous Detachment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterior vitreous detachment is a common event. With optical coherence tomography, the&#xD;
      investigators can precisely follow the stage of posterior vitrous detachment. In this study,&#xD;
      the investigators investigate if the loss of contact between the vitreous and the fovea is&#xD;
      the start of glaucoma progression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glaucoma progression</measure>
    <time_frame>1 day</time_frame>
    <description>glaucoma progression based on analysis of visual fields</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RNFL decr</measure>
    <time_frame>1 day</time_frame>
    <description>slope of decrease</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Glaucoma</condition>
  <condition>Posterior Vitreous Detachment</condition>
  <arm_group>
    <arm_group_label>with posterior vitreous detachment</arm_group_label>
    <description>patient with stage 3 or more of posterior vitreous detachment on optical coherence tomography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without posterior vitreous detachment</arm_group_label>
    <description>patient with stage 2 or less of posterior vitreous detachment on optical coherence tomography</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Retrospective cohort of patient with glaucoma follow in Montpellier hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patient with glaucoma&#xD;
&#xD;
          -  at least 4 years of follow up&#xD;
&#xD;
          -  at least 6 visual fields&#xD;
&#xD;
          -  at least 4 optical coherence tomographies&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  pars plana vitrectomy&#xD;
&#xD;
          -  others ophtalmological or neurological disease which can modify visual fields&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MAX VILLAIN, PHD</last_name>
    <role>Study Director</role>
    <affiliation>UH MONTPELLIER</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salami OSSENI, resident</last_name>
    <phone>65075430</phone>
    <phone_ext>33</phone_ext>
    <email>tunde.osseni@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Max VILLAIN, PhD</last_name>
      <phone>04 67 33 78 79</phone>
      <phone_ext>33</phone_ext>
      <email>ophtalmo@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>January 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 22, 2021</last_update_submitted>
  <last_update_submitted_qc>January 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Vitreous</keyword>
  <keyword>Progression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Vitreous Detachment</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
    <mesh_term>Dissociative Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

